KNTE   $2.65  -0.38% Market Closed

Kinnate Biopharma Inc
Total Cash 167.58M
totalCashPerShare 3.557
EBITDA -131.80M
Total Debt 3.38M
quickRatio 10.624
currentRatio 10.796
Total Revenue
debtToEquity 1.963
Revenue/Share
ROA -0.33628
ROE -0.55799
grossProfits
freeCashflow -59.61M
operatingCashflow -106.43M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -38.87M
forwardPE -2.548077
floatShares 22.68M
sharesOutstanding 47.17M
sharesShort 465.63K
sharesShortPriorMonth 1.08M
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.83%
Short Ratio help_outline 0.96%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 3.66
Price To Book help_outline 0.72
earningsQuarterlyGrowth
netIncomeToCommon -127.15M
trailingEps -2.78%
forwardEps -1.04%
enterpriseToEbitda 0.29
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.34 1Q 2024
institutionsCount 73
lastUpdated April 11, 2024, 7:31 p.m.